GlaxoSmithKline.

PositionRESEARCH TRIANGLE PARK

RESEARCH TRIANGLE PARK -- Novartis International AG will purchase London-based GlaxoSmithKline's cancer-drug business for up to $16 billion. GSK employs about 4,000 here and at other Triangle locations. GSK will buy the Basel, Switzerland-based...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT